News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
468,467 Results
Type
Article (23111)
Company Profile (157)
Press Release (445185)
Multimedia
Podcasts (114)
Webinars (17)
Section
Business (146053)
Career Advice (1186)
Deals (26524)
Drug Delivery (111)
Drug Development (58495)
Employer Resources (94)
FDA (9810)
Job Trends (9817)
News (244967)
Policy (21218)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (927)
Accelerated approval (21)
Adcomms (26)
Allergies (91)
Alliances (34788)
ALS (102)
Alzheimer's disease (959)
Antibody-drug conjugate (ADC) (230)
Approvals (10016)
Artificial intelligence (323)
Autoimmune disease (98)
Automation (18)
Bankruptcy (232)
Best Places to Work (7026)
BIOSECURE Act (14)
Biosimilars (175)
Biotechnology (72)
Bladder cancer (92)
Brain cancer (35)
Breast cancer (315)
Cancer (2781)
Cardiovascular disease (275)
Career advice (999)
Career pathing (25)
CAR-T (152)
CDC (15)
Cell therapy (395)
Cervical cancer (15)
Clinical research (51031)
Collaboration (1174)
Company closure (1)
Compensation (632)
Complete response letters (54)
COVID-19 (1325)
CRISPR (59)
C-suite (681)
Cystic fibrosis (99)
Data (3912)
Decentralized trials (2)
Denatured (28)
Depression (97)
Diabetes (303)
Diagnostics (3375)
Digital health (22)
Diversity (9)
Diversity, equity & inclusion (26)
Drug discovery (180)
Drug pricing (200)
Drug shortages (33)
Duchenne muscular dystrophy (157)
Earnings (63884)
Editorial (50)
Employer branding (15)
Employer resources (91)
Events (74277)
Executive appointments (804)
FDA (11715)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (11)
Funding (850)
Gene editing (106)
Generative AI (33)
Gene therapy (342)
GLP-1 (870)
Government (2228)
Grass and pollen (4)
Guidances (280)
Healthcare (9085)
HIV (36)
Huntington's disease (24)
IgA nephropathy (64)
Immunology and inflammation (187)
Immuno-oncology (39)
Indications (76)
Infectious disease (1481)
Inflammatory bowel disease (132)
Inflation Reduction Act (12)
Influenza (56)
Intellectual property (153)
Interviews (155)
IPO (11849)
IRA (54)
Job creations (2987)
Job search strategy (887)
JPM (53)
Kidney cancer (13)
Labor market (65)
Layoffs (390)
Leadership (29)
Legal (5543)
Liver cancer (45)
Longevity (9)
Lung cancer (382)
Lymphoma (254)
Machine learning (23)
Management (33)
Manufacturing (589)
MASH (122)
Medical device (5249)
Medtech (5266)
Mergers & acquisitions (15425)
Metabolic disorders (991)
Multiple sclerosis (108)
NASH (20)
Neurodegenerative disease (185)
Neuropsychiatric disorders (77)
Neuroscience (1787)
Neurotech (1)
NextGen: Class of 2026 (3357)
Non-profit (1444)
Now hiring (48)
Obesity (553)
Opinion (239)
Ovarian cancer (77)
Pain (155)
Pancreatic cancer (115)
Parkinson's disease (173)
Partnered (22)
Patents (305)
Patient recruitment (291)
Peanut (23)
People (44756)
Pharmaceutical (78)
Pharmacy benefit managers (33)
Phase 1 (15965)
Phase 2 (21835)
Phase 3 (17232)
Pipeline (3829)
Policy (236)
Postmarket research (1854)
Preclinical (5844)
Press Release (72)
Prostate cancer (151)
Psychedelics (30)
Radiopharmaceuticals (216)
Rare diseases (607)
Real estate (4201)
Recruiting (39)
Regulatory (16283)
Reports (30)
Research institute (995)
Resumes & cover letters (180)
Rett syndrome (24)
RNA editing (13)
RSV (43)
Schizophrenia (136)
Series A (146)
Series B (118)
Service/supplier (7)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (122)
Sponsored (21)
Startups (2458)
State (2)
Stomach cancer (13)
Supply chain (79)
Tariffs (94)
The Weekly (84)
Vaccines (472)
Venture capital (73)
Weight loss (389)
Women's health (47)
Worklife (9)
Date
Last 7 days (393)
Last 30 days (1291)
Last 365 days (19609)
2026 (2261)
2025 (19931)
2024 (23048)
2023 (26378)
2022 (34938)
2021 (36766)
2020 (34465)
2019 (27144)
2018 (20941)
2017 (21945)
2016 (20704)
2015 (24756)
2014 (20143)
2013 (16910)
2012 (18178)
2011 (18806)
2010 (17770)
Location
Africa (508)
Alabama (52)
Alaska (3)
Arizona (132)
Arkansas (8)
Asia (30984)
Australia (4143)
California (6774)
Canada (2253)
China (840)
Colorado (300)
Connecticut (310)
Delaware (218)
Europe (64146)
Florida (1144)
Georgia (147)
Hawaii (2)
Idaho (33)
Illinois (529)
India (60)
Indiana (335)
Iowa (13)
Japan (369)
Kansas (93)
Kentucky (32)
Louisiana (14)
Maine (55)
Maryland (746)
Massachusetts (5352)
Michigan (145)
Minnesota (351)
Mississippi (4)
Missouri (63)
Montana (21)
Nebraska (21)
Nevada (72)
New Hampshire (25)
New Jersey (2299)
New Mexico (23)
New York (1768)
North Carolina (1007)
North Dakota (5)
Northern California (3278)
Ohio (214)
Oklahoma (10)
Oregon (27)
Pennsylvania (1334)
Puerto Rico (22)
Rhode Island (33)
South America (753)
South Carolina (23)
Southern California (2735)
Tennessee (113)
Texas (985)
United States (24944)
Utah (168)
Virginia (222)
Washington D.C. (61)
Washington State (549)
West Virginia (3)
Wisconsin (82)
Wyoming (1)
468,467 Results for "mitsubishi tanabe pharma corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mitsubishi Tanabe Pharma America is Now Tanabe Pharma America
December 2, 2025
·
2 min read
Press Releases
Mitsubishi Tanabe Pharma America to Present Eight ALS Research Posters at 2025 NEALS Annual Meeting
October 3, 2025
·
9 min read
Press Releases
Mitsubishi Tanabe Pharma America to Present New Data on Investigational ND0612 at the 2025 International Congress of Parkinson’s Disease and Movement Disorders®
October 6, 2025
·
3 min read
Press Releases
Shionogi Expands Rare Disease Presence with Planned Acquisition of Global Rights to Tanabe Pharma Corporation’s RADICAVA ORS® (edaravone) and IV RADICAVA
December 23, 2025
·
9 min read
Press Releases
Mitsubishi Tanabe Pharma Canada, Inc. Announces Publication of Long-Term Function and Survival Analysis of RADICAVA® Oral Suspension (edaravone) -Treated Patients with ALS
September 5, 2025
·
6 min read
Press Releases
Mitsubishi Tanabe Pharma America Announces Publication of Long-Term Function and Survival Analysis of RADICAVA ORS® (edaravone)-Treated Patients with ALS
August 20, 2025
·
11 min read
Press Releases
Mitsubishi Tanabe Pharma America Highlights Parkinson’s Disease Research at 2025 EAN and ATMRD Congresses
June 23, 2025
·
4 min read
Press Releases
Tanabe Pharma America Announces Transfer of RADICAVA® Business to Shionogi
December 23, 2025
·
7 min read
Press Releases
Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation
February 7, 2025
·
4 min read
Deals
Two Private Equity Firms Near Potential $3B+ Deal for Mitsubishi’s Pharma Unit: Reuters
Blackstone and Bain Capital are said to be among the final bidders for the Japanese company’s Mitsubishi Tanabe Pharma, sources told Reuters Friday.
December 13, 2024
·
1 min read
·
Annalee Armstrong
1 of 46,847
Next
